Pharmaceutical Process Engineers are key players in the pharmaceutical industry, responsible for designing, developing, and scaling up processes to manufacture drugs efficiently and safely. They apply principles of catalysis and chemical engineering to optimize the synthesis of active pharmaceutical ingredients (APIs) and formulation processes, ensuring high product purity and consistency. Their expertise helps in meeting rigorous regulatory requirements while maximizing production yield and minimizing costs.
By utilizing advanced process simulation, modeling, and analytical tools, pharmaceutical process engineers fine-tune reaction conditions, separation techniques, and purification steps to achieve optimal performance. They work closely with chemists, quality assurance specialists, and regulatory bodies to translate laboratory-scale innovations into reliable commercial-scale manufacturing processes. Emphasizing sustainability, they integrate green chemistry approaches by employing energy-efficient catalytic reactions and minimizing waste generation. Their contributions not only accelerate drug development timelines but also improve environmental compliance and product safety. Continual innovation and process intensification strategies allow pharmaceutical process engineers to enhance production efficiency and adapt to evolving industry demands. Their work ultimately ensures the delivery of safe, effective, and affordable medications to patients worldwide. Additionally, they are instrumental in implementing continuous manufacturing technologies that improve process control and reduce production time. They also focus on scaling up biocatalytic processes, supporting the growth of biopharmaceuticals. Their role is critical in driving pharmaceutical innovation while maintaining strict safety and quality standards.
Title : Application of vanadium and tantalum single-site zeolite catalysts in catalysis
Stanislaw Dzwigaj, Sorbonne University, France
Title : 30,000 nano implants in humans with no infections, no loosening, and no failures
Thomas J Webster, Interstellar Therapeutics, United States
Title : Solar heterogeneous photocatalysis and photochemistry for urban wastewater regeneration and reuse
Isabel Oller Alberola, Plataforma Solar de Almería, Spain
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through biodesign-inspired & biotech-driven translational applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, R&D Director of the National Center for Human Photosynthesis, Mexico
Title : Human impact on natural environment and its implications
Dai Yeun Jeong, Asia Climate Change Education Center, Korea, Republic of
Title : Effect of bed material on syngas quality: Comparison of biomass gasification with different bed materials
Enrico Paris, CREA-IT & DIAEE, Italy
Title : Valorizing lignocellulose to ethylene glycol: Catalysis, catalyst deactivation and conceptual process design
Jean Paul Lange, University of Twente, Netherlands
Title : Design of nanocomposite materials for active components of structured catalysts for biofuels transformation into syngas, catalytic layers of membrane reactors with oxygen/hydrogen separation and anodes of solid oxide fuels cells operating in the internal reforming mode
Vladislav Sadykov, Boreskov Institute of Catalysis, Russian Federation
Title : Cleaner syngas from biomass gasification: Is K-Feldspar the key?
Beatrice Vincenti, Sapienza University of Rome, Italy
Title : Sustainable catalyst development: metal modified lignin-plastic composites for hydrogen production
Tahreem Saleem, University of Milano-Bicocca Italy, Italy